Marex Group (MRX) has wrapped up FY 2025 with Q4 revenue of US$572.1 million and basic EPS of US$1.19. This caps off a twelve month period that produced US$2.9 billion in revenue and basic EPS of US$4.32. Over the past year, the company has reported a net profit margin of 10.7% and earnings growth of 50.4%, alongside a five year average earnings growth rate of 32% per year. This frames the latest results as part of a broader profitability upswing that keeps margins firmly in focus for investors assessing the quality of these figures.

With the headline numbers on the table, the next step is to see how this earnings profile lines up against the widely held narratives around Marex Group, including what the community and analysts think about its growth, risks, and staying power.

50.4% earnings growth reshapes the story

• Over the last 12 months, Marex generated US$307.9 million of net income (excluding extra items), up from US$204.7 million a year earlier. This lines up with the 50.4% earnings growth figure and a net margin of 10.7% versus 8.7% previously.
• Bulls argue that rapid earnings growth, operational automation and strong client retention can keep earnings quality high, and the latest trailing numbers support parts of that, while also raising questions:
  • The five year average earnings growth of 32% per year sits below the latest 50.4% figure. Bullish investors may see this as evidence that recent execution and market conditions have been especially supportive.
  • At the same time, analysts in the supplied bullish view still expect revenue to decline by 4.3% per year over the next 3 years, so the strong trailing profit growth would need to be driven more by margins than by top line expansion.

Bulls who think this earnings jump is just the opening chapter often point to margin potential and client stickiness, and you can see that full argument here in the 🐂 Marex Group Bull Case

P/E of 9.3x vs peers at 17.7x

• Marex is quoted on a P/E of 9.3x, compared with peer and industry averages of 17.7x and 22.9x. Its current share price of US$39.94 sits below both the US$45.86 DCF fair value and the single allowed analyst price target of US$52.00.
• Skeptics highlight that despite this apparent discount, the shares may already reflect more cautious expectations, which fits with elements of the bearish narrative:
  • Consensus data in the inputs shows forecast earnings growth of about 9.5% per year, which is below the 15.5% figure cited for the broader US market. A lower P/E could therefore be linked to lower expected growth rather than market mispricing.
  • Revenue is expected to decline by around 9.9% per year over the next 3 years. Bears argue this could limit how much support the trailing 10.7% margin can give to future valuation multiples.

Bears who focus on slower forecast growth and revenue headwinds may see this valuation gap differently, and you can read that side of the argument here in the 🐻 Marex Group Bear Case

Debt coverage flagged despite higher margins

• While the company has moved from an 8.7% net margin to 10.7% on the trailing numbers, the risk data clearly flags that debt is not well covered by operating cash flow. This sits alongside forecasts for multi year revenue decline of roughly 9.9% per year.
• Consensus style views see Marex as benefiting from broader product breadth and technology investment, yet the balance sheet risk and revenue forecasts provide a counterweight to that story:
  • The same dataset that shows a 50.4% trailing earnings increase also notes that future earnings growth is expected to be around 9.5% per year. This is well below the recent pace and below the 15.5% figure referenced for the wider US market.
  • That mix of higher recent profitability, lower expected growth and flagged debt coverage means investors who are paying attention to cash generation and leverage, not just reported net income, may weigh these numbers carefully before leaning too hard into any single narrative.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Marex Group on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If this mix of strong recent profits and softer forecasts feels like a mixed message, take a moment to look through the numbers yourself and weigh the trade offs. Then see how they stack up against the 5 key rewards and 1 important warning sign.

See What Else Is Out There

Marex combines strong recent earnings with highlighted debt coverage concerns and forecasts for multi year revenue decline, which may leave you preferring a sturdier balance sheet story.

If that mix feels a bit exposed, take a closer look at our solid balance sheet and fundamentals stocks screener (41 results) to quickly focus on companies where cash flow coverage appears more robust.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.